107.521 articles found

Using High-Content Screening Technology as a Tool to Generate Single-Cell Patient-Derived Gene-Corrected Isogenic iPS Clones for Parkinson’s Disease Research

Barbuti PA, Antony PM, Santos BF, Massart F, Cruciani G, Dording CM, Arias J, Schwamborn JC, Krüger R.

· 2020-05-02

DOI: 10.20944/preprints202005.0001.v1

Dysautonomia in early Parkinson disease: a window into the determinants of functional disability and an opportunity for early intervention.

Merola A, Coon EA.

Clin Auton Res · 2020-05-02

DOI: 10.1007/s10286-020-00684-3PMID: 32361782

What's wrong with the striatal cholinergic interneurons in Parkinson's disease? Focus on intrinsic excitability.

Tubert C, Murer MG.

Eur J Neurosci · 2020-05-02

DOI: 10.1111/ejn.14742PMID: 32302030

M145. ALTERED SUBCORTICAL EMOTIONAL SALIENCE PROCESSING AND A ‘JUMPING TO CONCLUSIONS’ BIAS IN PARKINSON’S PATIENTS WITH PSYCHOTIC SYMPTOMS

Knolle F, Garofalo S, Viviani R, Ermakova A, Murray G.

Schizophrenia bulletin · 2020-05-01

Impaired hand dexterity function in a non-human primate model with chronic Parkinson’s disease

Seo J, Won J, Kim K, Park J, Yeo H, Kim YG, Baek SH, Lee H, Jeon C, Choi WS, Lee S, Kim KJ, Park S, Son Y, Jeong KJ, Lim KS, Kang P, Lee H, Son H, Huh J, Kim Y, Jin YB, Lee D, Lee S, Choi J, Lee Y.

· 2020-05-01

DOI: 10.1101/2020.05.01.072058

Pharmacoeconomic Review Report: Safinamide (Onstryv): (Valeo Pharma Inc.): Indication: For add-on therapy to a regimen that includes levodopa for the treatment of the signs and symptoms of idiopathic Parkinson disease (PD) in patients experiencing “OFF” episodes while on a stable dose of levodopa. Safinamide has not been shown to be effective as monotherapy for the treatment of PD

Check source for author details

· 2020-05-01

PMID: 33231958

Clinical Review Report: Safinamide (Onstryv): (Valeo Pharma Inc.): Indication: For add-on therapy to a regimen that includes levodopa for the treatment of the signs and symptoms of idiopathic Parkinson disease (PD) in patients experiencing “off” episodes while on a stable dose of levodopa. Safinamide has not been shown to be effective as monotherapy for the treatment of PD

Check source for author details

· 2020-05-01

PMID: 33231957

The Cataleptic, Asymmetric, Analgesic, and Brain Biochemical Effects of Parkinson's Disease Can Be Affected by <i>Toxoplasma gondii</i> Infection.

Taherianfard M, Riyahi M, Razavi M, Bavandi Z, Eskandari Roozbahani N, Namavari MM.

Biomed Res Int · 2020-05-01

DOI: 10.1155/2020/2546365PMID: 32461971

Examining Factors Related to Health-Related Quality of Life in People With Parkinson's Disease.

Kwok JYY, Auyeung M, Chan HYL.

Rehabil Nurs · 2020-05-01

DOI: 10.1097/rnj.0000000000000179PMID: 30005001

Parkinson's Disease: Exploring Motives for Long-Term Adherence to a Group Exercise Program.

Cleary AS, Rossi A, States RA.

Rehabil Nurs · 2020-05-01

DOI: 10.1097/rnj.0000000000000187PMID: 30272624

Preserved Serotonergic Activity in Early-Onset Parkinson's Disease.

Park HK, Lee JJ, Park YM.

Can J Neurol Sci · 2020-05-01

DOI: 10.1017/cjn.2019.322PMID: 31685057

[Inpatient treatment costs, cost-driving factors and potential reimbursement problems due to fall-related fractures in patients with Parkinson's disease].

Verboket RD, Mühlenfeld N, Woschek M, Marzi I, Pieper M, Zöllner JP, Strzelczyk A, Willems LM.

Chirurg · 2020-05-01

DOI: 10.1007/s00104-019-01074-wPMID: 31807819